HIGH COURT OF DELHI
AGRIVIDA INC – Appellant
Versus
UNION OF INDIA AND THE CONTROLLER GENERAL OF PATENTS – Respondent
W.P.(C)-IPD-84/2021
$~14
*
IN THE HIGH COURT OF DELHI AT NEW DELHI
Date of Decision: 23rdMay, 2022
+
W.P.(C)-IPD 84/2021
AGRIVIDA INC
..... Petitioner
Through:
Mr.
Rajiv
Kumar
Choudhry,
Advocate (M:9811028098)
versus
UNION OF INDIA AND THE CONTROLLER GENERAL OF
PATENTS
..... Respondent
Through:
Mr. Manish Mohan, CGSC with Mr.
Devendra
Kumar,
Ms.
Manisha
Saroha, Advocates (M:9999910115)
CORAM:
JUSTICE PRATHIBA M. SINGH
Prathiba M. Singh, J. (Oral)
1.
This hearing has been done through hybrid mode.
2.
The present petition has been preferred by the Petitioner challenging
the Office Circular No. 2 of 2010, dated 12thJanuary, 2010 (hereinafter,
“Impugned Circular”) issued by the Controller General of Patents, Designs
and Trade Marks. The Petitioner herein regularly files patent applications for
gene sequences before the Indian Patent Office. For the said purpose, the
Petitioner was liable to pay official fee on the basis of the total number of
pages in the application, including sequence listings, which run into
thousands of pages. The Impugned Circular under challenge is set out
below:
informed to all stakeholders that filing of sequence
listing in Print Form is mandatory as it forms a part
of patent specification. It is also required to file the
This is a digitally signed Judgement.
NEUTRAL CITATION NO: 2022/DHC/002105
Rules, 2003 (as amended). If number of pages of the
patent specification including sequence listing in
print form exceeds thirty, extra fee will be charged as
per provisions made in the First Schedule of the
Patent Rules.”
3.
As per the Impugned Circular, the amount of official fee payable has
been prescribed under the First Schedule of the Patent Rules, 2003. At the
time when the present writ petition was filed, the said Schedule stipulated as
under:
4.
In effect, the challenge is to the high amount of official fees payable
This is a digitally signed Judgement.
NEUTRAL CITATION NO: 2022/DHC/002105
by Applicants in patent applications relating to gene sequences where the
sequence can run into thousands of pages as the fees is calculated on a per
page basis.
5.
The background of the present petition is that the Petitioner filed three
PCT applications being PCT/US2005/017700, PCT/US2010/055669, and
PCT/US2010/055751 for three separate gene sequences. Amongst the said
three applications, Patent Application No.PCT/US2005/017700 was carried
into the National Phase in India. However, it is the case of the Petitioner that
the remaining two PCT applications being PCT/US2010/055669, and
PCT/US2010/055751, could not enter the National Phase in India on
account of the exorbitant/prohibitive official fee that was required to be
deposited by the Petitioner with the Respondent-Indian Patent Office.
6.
The details of the three PCT applications filed by the Petitioner,
including the total number of pages in each of the applications, are set out
below:
PCT/US2005/017700
[Indian
Patent
Application
No.6939/DELNP/2006]
This is a digitally signed Judgement.
NEUTRAL CITATION NO: 2022/DHC/002105
PCT/US2010/055669
PCT/US2010/055751
7.
As per the Impugned Circular read along with the First Schedule of
the Patent Rules, 2003 as it stood prior to amendments, the PCT applications
This is a digitally signed Judgement.
NEUTRAL CITATION NO: 2022/DHC/002105
of the Petitioner would have attracted official fee, to the following effect:
PCT/US2010/055669
PCT/US2010/055751
8.
Pertinently, as stated in the petition, in the absence of the Impugned
Circular, the Petitioner would have been liable to pay Rs.96,800/- qua
PCT/US2010/055669 and Rs.88,800/- qua PCT/US2010/055751 as filing
fee to the Indian Patent Office. However, in view of the circular, the official
fees payable would have been in lakhs of rupees to obtain patents for the
This is a digitally signed Judgement.
NEUTRAL CITATION NO: 2022/DHC/002105
subject gene sequences.
9.
It is submitted on behalf of the Petitioner that in the case of patent
applications containing gene sequences, the applications/sp